Acquisition Synergy Radcal’s acquisition by IBA Dosimetry and the recent Accu-Gold Mobile launch create a compelling opportunity to position complementary QA solutions and cross-sell integrated X-ray beam QA tools to existing IBA customers seeking expanded US footprint and enhanced mobile capabilities.

US Market Footprint With a lean team (11-50 employees) and a strong Made in USA heritage, Radcal presents a gap-filling option for buyers seeking localized support, faster service, and high-precision diagnostic radiology QA equipment in the US market.

Mobile QA Push The debut of Accu-Gold Mobile signals demand for portable, smartphone-based QA solutions. A sales approach that emphasizes field efficiency, remote diagnostics, and quick QA cycles can attract clinics and imaging centers aiming to reduce downtime and improve throughput.

Legacy Reliability Radcal’s long-standing Gold Standard Ion Chamber technology and durable, USA-made quality can be leveraged to target customers requiring proven, high-accuracy dose measurements, especially in hospitals and radiology departments with strict QA standards.

Technology Stack Fit Current tech stack familiarity with cloud platforms and web interfaces suggests potential for upsell of cloud-based data management, remote reporting, and integrated QA analytics to larger centers already using similar digital ecosystems.